Cosmederm-7 "substantially reduces" AHA irritation, company chief says.
This article was originally published in The Rose Sheet
Executive Summary
COSMEDERM-7 ANTI-IRRITANT "SUBSTANTIALLY REDUCES" AHA IRRITATION, making it possible to formulate "very high efficacy" alpha hydroxy products without side effects that are unacceptable to the consumer, Cosmederm Technologies President and Chief Technical Officer Gary Hahn, MD, said at a June 11 seminar at the HBA Global Expo in New York City. Cosmederm-7 is "a potent and selective inhibitor of sting, burn and itch for cosmetics" that "offers highly effective, long duration anti-irritant activity against a wide variety of chemical ingredients" found in AHA products, antiperspirants, anti-acne agents and depilatories, according to the company. Privately held Cosmederm Technologies, headquartered in La Jolla, Calif., "develops and commercializes innovative neurosensory-based technologies for the cosmetics, personal care and pharmaceutical industries," the firm said.